Statistically significant difference for HB was found among MPNs with JAK2 V617F mutation positive vs negative (mean HB difference = 1.54 g/dL, p < 0.001), and among MPN sub-types (p < 0.001). This evidence concerns the gene JAK2 and myeloproliferative neoplasm.